IX
ORIX Corporation
There isn't enough reported data to score IX yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
IX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| N/A | |
| N/A |
IX's profitability is currently strong. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like IX.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
IX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.8x | $34.08 | — |
| Cheap | 8.7x | $51.41 | +51% |
| Fair | 11x | $67.56 | +98% |
| Expensive | 14x | $82.03 | +141% |
Historical ranges are pointers, not guarantees.
IX has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
IX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect IX's earnings and revenue to decline, with profitability weakening.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over IX on the outlook, with more favorable earnings and revenue expectations.
IX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $5.90 | +143% |
| Q1 2026 | $2.49 | +122% |
| Q1 2025 | $1.12 | +203% |
| Q1 2024 | $0.37 | +28% |
| Q4 2023 | $0.30 | -9.1% |
| Q3 2023 | $0.30 | 0% |
| Q1 2023 | $0.29 | -9.4% |
| Q4 2022 | $0.33 | +22% |
IX has the edge over JPM in the latest year-over-year earnings comparison.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
IX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $10.5B | +7% |
| Q1 2026 | $11.1B | +20% |
| Q3 2025 | $9.8B | +11% |
| Q1 2025 | $9.2B | -48% |
| Q3 2024 | $8.8B | +3.2% |
| Q1 2024 | $17.6B | +319% |
| Q4 2023 | $4.3B | +7.6% |
| Q3 2023 | $8.5B | -0.4% |
IX has the edge over JPM in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +0.3 points |
| Q1 2026 | 12% | -0.7 points |
| Q3 2025 | 16% | +1.3 points |
| Q1 2025 | 9.2% | -2.9 points |
| Q3 2024 | 14% | +2.6 points |
| Q1 2024 | 13% | -1.2 points |
| Q4 2023 | 14% | +3.3 points |
| Q3 2023 | 12% | +9 points |
IX's operating margin was 14% last quarter, about level with the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over IX on profitability, with a higher operating margin.
IX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.8B | +4.6% |
| Q1 2026 | $4.5B | +9.3% |
| Q3 2025 | $3.6B | +0.5% |
| Q1 2025 | $4.1B | -44% |
| Q3 2024 | $3.6B | +4.1% |
| Q1 2024 | $7.3B | +283% |
| Q4 2023 | $2B | +15% |
| Q3 2023 | $3.5B | +143% |
IX's free cash flow was $16B over the past year, down 2.2% from the year before. Free cash flow isn't a meaningful measure for financial services companies like IX.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
IX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.4% | -27M shares |
| 1 year | -81% | -4.7B shares |
| 3 years | -82% | -4.9B shares |
| 5 years | -83% | -5.3B shares |
| Available history | -83% | -5.4B shares |
IX has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $933.4M |
| Q1 2026 | $490.9M |
| Q3 2025 | $449.3M |
| Q1 2025 | $113.5M |
| Q3 2024 | $222M |
| Q1 2024 | $313.4M |
| Q4 2023 | $116.1M |
| Q3 2023 | $197.3M |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
IX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q3 2025 | 6.8x | High |
| Q1 2025 | 6.9x | High |
| Q1 2024 | 7.1x | High |
| Q4 2023 | 7.2x | High |
| Q3 2023 | 7.4x | High |
| Q1 2023 | 6.7x | High |
IX's net debt is about 5.7 years of its operating earnings (EBITDA), down from 7.1 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IX.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over IX on leverage, with a lower net debt burden relative to earnings.
IX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.3 | Neutral |
| Stochastic | 11.3 | Oversold |
IX's weekly RSI is 38 (neutral) and its Stochastic is 11 (oversold).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
IX PE vs Financial Services Sector
| Metric | IX | Sector median | Relative |
|---|---|---|---|
| PE | 5.8x | 13x | 56% below |
| PE % | 5 | 63 | 58 pts below |
IX has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
IX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.6 | 6.8% below |
| 20 week MA | $38.4 | 11% below |
| 50 week MA | $35.1 | 2.9% below |
| 100 week MA | $28.9 | 18% above |
| 200 week MA | $24.4 | 40% above |
IX has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 40% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over IX on trend strength, trading above more of its moving averages.
IX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.6 | $14.8 | -11% |
| 2021 | $14.8 | $20.2 | +36% |
| 2022 | $20.2 | $16.3 | -19% |
| 2023 | $16.3 | $18.7 | +15% |
| 2024 | $18.7 | $21.4 | +15% |
| 2025 | $21.4 | $29.4 | +37% |
| 2026 YTD | $29.4 | $34.1 | +16% |
IX has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.